Single Polycistronic Lentiviral Vector for iPS Cell Derivation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for deriving induced pluripotent stem cells (iPS cells) require multiple viral vectors to deliver transcription factors, leading to high genomic integrations and difficulties in producing safer cells with minimal viral integrations, which limits their clinical applications.
Innovation Solution
A single lentiviral vector expressing multiple transcription factor proteins from a multi-cistronic mRNA is used to reprogram fibroblast cells into stem cell-like cells, with an excisable polycistronic vector to achieve transgene-free iPS cells and improve their developmental potential.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple individual viral vectors are used to deliver transcription factors for iPS cell derivation, then complete delivery of all required factors can be achieved, but high numbers of genomic integrations occur making genetic elimination difficult
Solution Approach 1:
The patent combines multiple transcription factor genes (OCT4, SOX2, KLF4, c-MYC) into a single polycistronic lentiviral vector construct. This merging approach delivers all required factors simultaneously through one viral integration event, achieving complete factor delivery while minimizing the number of genomic integrations from 4 separate vectors to just 1 vector.
Solution Approach 2:
The single lentiviral vector is designed to perform multiple functions: it delivers all four transcription factors required for reprogramming, provides a selectable marker for identifying successfully transduced cells, and includes excision sequences for later removal of the viral construct. This multi-functionality eliminates the need for separate vectors for each function.
2Reliability
If multiple viral vectors are applied to deliver transcription factors, then all factors can be delivered to target cells, but it becomes difficult to study reprogramming biochemistry on a homogeneous population
Solution Approach 1:
By merging all transcription factor genes into a single polycistronic vector, the patent ensures that every successfully transduced cell receives the complete set of four transcription factors simultaneously. This creates a homogeneous population of reprogramming-competent cells, enabling consistent biochemical studies without the variability introduced by cells receiving different numbers of factors from multiple separate vectors.
3Object-affected harmful factors
If a single lentiviral vector expresses multiple transcription factors from multi-cistronic mRNA, then viral integrations are minimized, but efficient expression of all transcription factor proteins must be achieved
Solution Approach 1:
The patent uses self-cleaving 2A peptide sequences as intermediaries between adjacent transcription factor coding regions in the polycistronic construct. These 2A peptides mediate ribosomal skipping during translation, causing the ribosome to cleave the nascent polypeptide chain at specific sites and release individual transcription factor proteins from the multi-cistronic mRNA transcript, thereby enabling efficient expression of multiple proteins from a single mRNA molecule.
Solution Approach 2:
The patent replaces the mechanical system of multiple separate transcription events (requiring multiple promoters and vectors) with a single transcription event producing a multi-cistronic mRNA. The translation system is then harnessed to produce multiple proteins through ribosomal frameshifting and 2A-mediated cleavage, substituting a complex multi-vector mechanical delivery system with a more efficient single-vector molecular biology approach.
Data Source
AI summary
The present invention is based on the discovery that a single lentiviral vector expressing multiple individual transcription factor proteins from a single multi-cistronic mRNA can reprogram a fibroblast cell to a stem cell-like cell. These reprogrammed induced pluripotent stem (iPS) cells are pluripotent. Additions of the Cre-LoxP sequences into the single lentiviral vector facilitate excision of the vector after reprogramming in achieved. Addition of a maker gene into the single lentiviral vector facilitates detection of the presence of the vector in an iPS. The invention provides compositions and methods of producing iPS cells using a single multi-cistronic lentiviral vector.